Adipocyte-specific deletion of gp130 prevents ketogenic diet-induced hepatic steatosis
{{output}}
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD), the hepatic manifestation of obesity and type 2 diabetes, can progress to metabolic dysfunction-associated steatohepatitis and fibrosis. MASLD is chara... ...
